ResearcherUniversity of PaduaNo recent work listed
Simone Serafini
Matched on ORCID iD 0000-0003-1465-8439; OpenAlex author ID A5084375915. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 1 paper
Papers 8
- Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature. Co-author DOI 10.12998/wjcc.v11.i28.6823↗
- The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic liter… Co-author DOI 10.1007/s12149-021-01629-0↗
- Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer. Co-author DOI 10.3390/cancers13061277↗
- Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/cancers13225803↗
- The Prognostic Value of Low Muscle Mass in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/jcm10143033↗
- Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer. Co-author DOI 10.3390/jcm9072169↗
- Surgery for Recurrent Pancreatic Cancer: Is It Effective? First author DOI 10.3390/cancers11070991↗
- Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept. Co-author DOI 10.1016/j.ijsu.2015.04.093↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cosimo Sperti · 7 shared papers, 2019–2023 · strength 1.01
- Paper Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature. DOI 10.12998/wjcc.v11.i28.6823↗
- Paper Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer. DOI 10.3390/cancers13061277↗
- Paper Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-A… DOI 10.3390/cancers13225803↗
- Lucia Moletta · 7 shared papers, 2019–2023 · strength 1.01
- Paper Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature. DOI 10.12998/wjcc.v11.i28.6823↗
- Paper Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer. DOI 10.3390/cancers13061277↗
- Paper Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-A… DOI 10.3390/cancers13225803↗
- Elisa Sefora Pierobon · 3 shared papers, 2019–2023 · strength 0.46
- Paper Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature. DOI 10.12998/wjcc.v11.i28.6823↗
- Paper The Prognostic Value of Low Muscle Mass in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. DOI 10.3390/jcm10143033↗
- Paper Surgery for Recurrent Pancreatic Cancer: Is It Effective? DOI 10.3390/cancers11070991↗
- Andrea Grego · 2 shared papers, 2020–2021 · strength 0.27
- Paper Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-A… DOI 10.3390/cancers13225803↗
- Paper Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer. DOI 10.3390/jcm9072169↗
- Andrea Costantini · 1 shared paper, 2023 · strength 0.22
- Diego Cecchin · 1 shared paper, 2021 · strength 0.13
- Laura Evangelista · 1 shared paper, 2021 · strength 0.13
- Francesca Bergamo · 1 shared paper, 2021 · strength 0.13
- Stefano Merigliano · 1 shared paper, 2021 · strength 0.12
- Marco Cannistrà · 1 shared paper, 2015 · strength 0.06
- Bruno Nardo · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.